Chronic Obstructive Pulmonary Disease (COPD) – Epidemiological Forecast

0

The report “Chronic Obstructive Pulmonary Disease (COPD) – Epidemiological Forecast – 2030” provides an in-depth understanding of Chronic Obstructive Pulmonary Disease (COPD), historical and predicted epidemiology, and trends in Chronic Obstructive Pulmonary Disease (COPD) in the USA. United States, EU5 (Germany, France, Italy, Spain and United Kingdom) and Japan.

New York, August 24, 2021 (GLOBE NEWSWIRE) – Reportlinker.com announces the publication of the report “Chronic Obstructive Pulmonary Disease (COPD) – Epidemiology Forecast-2030” – https://www.reportlinker.com/p06129795/? Utm_source = GNW

Chronic Obstructive Pulmonary Disease (COPD) Understanding the Disease
Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable, and treatable disease characterized by persistent respiratory symptoms and limited airflow due to airway and / or alveolar abnormalities typically caused by heavy exposure to particulate matter. or harmful gases.
The most common respiratory symptoms include dyspnea, cough, and / or sputum production; these symptoms may be underreported by patients. The main risk factor for COPD is smoking, but other environmental exposures such as exposure to biofuels and air pollution can contribute. In addition to exposures, host factors predispose individuals to developing COPD. These include genetic abnormalities, abnormal lung development, and accelerated aging. COPD can be punctuated by periods of acute worsening of respiratory symptoms, called exacerbations. In most patients, COPD is associated with significant concomitant chronic diseases, which increase its morbidity and mortality. COPD is a long-lasting lung disease where the small airways in the lungs are damaged, making it harder for air to get in and out.
Continued in the report… ..

Epidemiological perspective of chronic obstructive pulmonary disease (COPD)
The disease epidemiology covered in the report provides historical and predicted epidemiology segmented by total number of prevalent cases diagnosed with chronic obstructive pulmonary disease (COPD), prevalent cases diagnosed by sex of chronic obstructive pulmonary disease (COPD), prevalent cases diagnosed by age. Chronic Obstructive Pulmonary Disease (COPD), prevalent cases diagnosed with COPD based on severity of airflow limitation and prevalent cases diagnosed with COPD based on symptoms and exacerbation scenario in the 7MM scenario covering the United States, EU5 countries (Germany, France, Italy, Spain and United Kingdom) and Japan from 2018 to 2030.

Detailed epidemiological segmentation of chronic obstructive pulmonary disease (COPD)
• The total population diagnosed with prevalent chronic obstructive pulmonary disease (COPD) in seven major markets was 31,730,590 in 2020 and is expected to increase in 2030.
• Estimates suggest a higher diagnosed prevalence of COPD in the United States with 17,455,605 cases diagnosed in 2020, which could increase in 2030.
• The majority of cases of chronic obstructive pulmonary disease (COPD) are women compared to men in the United States. But in the EU-5 and Japan, cases diagnosed in men represent the majority of cases.
• In the epidemiological model of chronic obstructive pulmonary disease (COPD), several age groups are referred, ranging from 18 to 44 years, 45 to 54 years, 55 to 64 years, 64 to 74 years and 75 years and over, for COPD in the United States. The highest was 4,601,558 in the 55-64 age group in 2020.
• In 2020, the United States had 2,967,453, 8,727,802, 4,538,457 and 1,221,892 cases of GOLD 1, GOLD 2, GOLD 3 and GOLD 4.

Scope of the report
• The report covers a descriptive overview of chronic obstructive pulmonary disease (COPD), explaining its causes, symptoms, pathophysiology and genetic basis.
• The report provides an overview of the historical and projected 7 MM patient pool covering the US, EU5 countries (Germany, France, Italy, Spain and UK) and Japan.
• The report assesses the risk and burden of disease and highlights the unmet needs of chronic obstructive pulmonary disease (COPD).
• The report helps to recognize growth opportunities in 7MM with respect to the patient population.
• The report provides segmentation of disease epidemiology for 7 MM of diagnosed prevalent cases of chronic obstructive pulmonary disease (COPD), prevalent cases diagnosed with gender-specific chronic obstructive pulmonary disease (COPD), prevalent cases diagnosed with pulmonary disease. chronic obstructive system as a function of age. Disease (COPD), prevalent cases diagnosed with COPD based on severity of airflow limitation and prevalent cases diagnosed with COPD based on symptoms and history of exacerbation.

Highlights of the report
• 10-year forecast of chronic obstructive pulmonary disease (COPD)
• Coverage of 7 MM
• Prevalent cases diagnosed with chronic obstructive pulmonary disease (COPD)
• Prevalent cases diagnosed by sex of chronic obstructive pulmonary disease (COPD)
• Prevalent cases diagnosed by age of chronic obstructive pulmonary disease (COPD)
• Prevalent cases diagnosed with COPD based on severity of airflow limitation
• Prevailing cases diagnosed with COPD on the basis of symptoms and history of exacerbation

Answers to key questions
• What are the disease risk and burden of chronic obstructive pulmonary disease (COPD)?
• What is the historical pool of patients with chronic obstructive pulmonary disease (COPD) in the United States, the EU5 (Germany, France, Italy, Spain and United Kingdom) and Japan?
• What would be the predicted patient pool for chronic obstructive pulmonary disease (COPD) at the 7 MM level?
• What will be the growth opportunities in the 7MM with respect to the patient population with chronic obstructive pulmonary disease (COPD)?
• Among the countries mentioned above, which country would have the highest prevalence of chronic obstructive pulmonary disease (COPD) during the forecast period (2021-2030)?
• At what CAGR is the population expected to grow over the 7 MM during the forecast period (2021-2030)?

Reasons to buy
The Chronic Obstructive Pulmonary Disease (COPD) report will allow the user to –
• Develop business strategies by understanding the trends that shape and guide the epidemiological forecast of 7MM Chronic Obstructive Pulmonary Disease (COPD).
• The Chronic Obstructive Pulmonary Disease (COPD) Epidemiology Report and Model was written and developed by masters and doctoral students. level epidemiologists.
• The chronic obstructive pulmonary disease (COPD) epidemiology model developed is easy to navigate, interactive with dashboards and epidemiology based on transparent and consistent methodologies. Additionally, the model supports the data presented in the report and presents disease trends over the 10-year forecast period using reliable sources.

Key evaluations
• Patient segmentation
• Risk of disease and burden
• Risk of disease by segmentation
• Factors driving the growth of a specific patient population

Geographical areas covered
• United States
• EU5 (Germany, France, Italy, Spain and United Kingdom)
• Japan
Study period: 2018-2030

Read the full report: https://www.reportlinker.com/p06129795/?utm_source=GNW

About Reportlinker
ReportLinker is an award winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________

CONTACT: Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001

Leave A Reply

Your email address will not be published.